These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29956813)

  • 1. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.
    Liu M; Zhang X; Cai J; Li Y; Luo Q; Wu H; Yang Z; Wang L; Chen D
    Oncol Rep; 2018 Sep; 40(3):1251-1260. PubMed ID: 29956813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
    Liu X; Long Z; Cai H; Yu S; Wu J
    Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
    Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
    Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
    Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
    World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer.
    Kang J; Kang YH; Oh BM; Uhm TG; Park SY; Kim TW; Han SR; Lee SJ; Lee Y; Lee HG
    Tumour Biol; 2016 Oct; 37(10):13843-13853. PubMed ID: 27485112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of long non‑coding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelial‑mesenchymal transition in colorectal cancer cells.
    Yang X; Liu W; Xu X; Zhu J; Wu Y; Zhao K; He S; Li M; Wu Y; Zhang S; Cao J; Ye Z; Xing C
    Oncol Rep; 2018 Sep; 40(3):1554-1564. PubMed ID: 30015983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
    Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of interleukin‑17F in colorectal cancer promotes tumor invasion by inducing epithelial‑mesenchymal transition.
    Chen Y; Yang Z; Wu D; Min Z; Quan Y
    Oncol Rep; 2019 Sep; 42(3):1141-1148. PubMed ID: 31322258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma.
    Zhang W; Cui Q; Qu W; Ding X; Jiang D; Liu H
    Oncol Rep; 2018 Jul; 40(1):206-216. PubMed ID: 29749538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
    Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
    Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Novel Target of Colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion via Activation of CXCR4/NF-κB Signaling.
    Kou T; Sha D; Wang F; He T; He X
    Cell Biochem Biophys; 2021 Mar; 79(1):113-121. PubMed ID: 33151473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MIR503HG is downregulated in Han Chinese with colorectal cancer and inhibits cell migration and invasion mediated by TGF-β2.
    Chuo D; Liu F; Chen Y; Yin M
    Gene; 2019 Sep; 713():143960. PubMed ID: 31278965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
    Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
    Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
    Qiu X; Huang Y; Zhou Y; Zheng F
    Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.